Expertise in
12
conditions

Georg Stussi

Bellinzona, TI, CH 
Expertise in
12
conditions
Bellinzona, TI, CH 

Overview

Georg Stussi practices practicing medicine in Bellinzona, Switzerland.

Mr. Stussi is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Leukemia, Marginal Zone Lymphoma (MZL), Chronic Lymphocytic Leukemia (CLL), Tissue Biopsy, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 95 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Bellinzona, TI, Switzerland
Other Locations
Bellinzoona, Switzerland
Lugano, TI, Switzerland
Bern, BE, Switzerland
Zurich, ZH, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Open-label, Randomized, Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes With Excess Blasts-2 (MDS-EB2) With FLT3 Mutations Eligible for Intensive Chemotherapy (HOVON 156 AML / AMLSG 28-18)
A Phase 3, Multicenter, Open-label, Randomized, Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes With Excess Blasts-2 (MDS-EB2) With FLT3 Mutations Eligible for Intensive Chemotherapy (HOVON 156 AML / AMLSG 28-18)
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2024
Intervention Type: Drug
Study Drugs: Gilteritinib, Midostaurin
Study Phase: Phase 3
Treatment Optimization of Newly Diagnosed Ph/BCR-ABL Positive Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase With Nilotinib vs. Nilotinib Plus Interferon Alpha Induction and Nilotinib or Interferon Alpha Maintenance Therapy
Treatment Optimization of Newly Diagnosed Ph/BCR-ABL Positive Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase With Nilotinib vs. Nilotinib Plus Interferon Alpha Induction and Nilotinib or Interferon Alpha Maintenance Therapy
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug
Study Drugs: Peginterferon ?2b, Nilotinib
Study Phase: Phase 3
View 1 Less Clinical Trial

95 Total Publications

Thrombotic microangiopathy following CAR T-cell therapy: a case series from the EBMT Complications Working Party.
Thrombotic microangiopathy following CAR T-cell therapy: a case series from the EBMT Complications Working Party.
Journal: Haematologica
Published: June 02, 2026

Frequently Asked Questions about Georg Stussi

Is Georg Stussi a top-rated expert for Leukemia?

MediFind is an objective health platform that identifies experts based on real-world data. Georg Stussi is classified as an Advanced expert for Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Georg Stussi participate in research or clinical trials?

Yes. Georg Stussi has published 95 articles and abstracts on conditions like Leukemia. You can view a list of Georg Stussi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Stussi's expertise for a condition
ConditionClose
      View All 12 Advanced Conditions
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile